Evidence map›Paper›PMID 23397531›Full record

ReviewSeminars in liver disease2012

Clues to the etiology of bile duct injury in biliary atresia.

Cara L Mack, Amy G Feldman, Ronald J Sokol

Registry-linked trialAbstract readReview
In one paragraph

Review in Seminars in liver disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03890536 (Intestinal Microbiome Composition in Infants With Biliary Atresia), which is not on this map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03890536 withdrawnnot on this mapstarted 2023, after this paper: background citation

Intestinal Microbiome Composition in Infants With Biliary Atresia

TypeobservationalSponsorChildren's Hospital Medical Center, CincinnatiRan2023 to 2032Enrolled0ConditionsBiliary Atresia, Intrahepatic Cholestases, Normal Controls
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Efficacy and safety of post-Kasai steroid-based protocol in biliary atresia.Journal of pediatric gastroenterology and nutrition · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Progress in Biomarkers Related to Biliary Atresia.Journal of clinical and translational hepatology · 2024
    Review
  8. Article
  9. Contribution ofInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. The synthetic toxin biliatresone causes biliary atresia in mice.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cara L MackDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado School of Medicine, and Digestive Health Institute, Children's Hospital Colorado, Aurora, Colorado 80045, USA.
Amy G Feldman
Ronald J Sokol
Children's Hospital Colorado · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Etiology and Treatment of Biliary Atresia and INHU01DK062453 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI RONALD J. SOKOL · 2002 to 2026
$13.5M
Institutional Training Grant in Pediatric GastroenterologyT32DK067009 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI RONALD J. SOKOL, Edwin Fulco de Zoeten · 2005 to 2026
$7.1M
T Cell-Mediated Mechanisms of Autoimmunity in Murine and Human Biliary AtresiaR01DK078195 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MACK, CARA LYNN · 2007 to 2011
$1.5M
NCRR NIH HHS UL1 RR025780NCRR NIH HHS UL1RR025780NIDDK NIH HHS DK067009NIDDK NIH HHS R01 DK078195NIDDK NIH HHS T32 DK067009NIDDK NIH HHS U01 DK062453NIDDK NIH HHS U01DK062453
6 · The paper itself

Abstract

Biliary atresia (BA) is an infantile obstructive cholangiopathy of unknown etiology with suboptimal therapy, which is responsible for 40 to 50% of all pediatric liver transplants. Although the etiology of bile duct injury in BA in unknown, it is postulated that a pre- or perinatal viral infection initiates cholangiocyte apoptosis and release of antigens that trigger a Th1 immune response that leads to further bile duct injury, inflammation, and obstructive fibrosis. Humoral immunity and activation of the innate immune system may also play key roles in this process. Moreover, recent investigations from the murine BA model and human data suggest that regulatory T cells and genetic susceptibility factors may orchestrate autoimmune mechanisms. What controls the coordination of these events, why the disease only occurs in the first few months of life, and why a minority of infants with perinatal viral infections develop BA are remaining questions to be answered.

Indexed as

AutoimmunityBiliary AtresiaEpigenesis, GeneticGenetic Predisposition to DiseaseHumansImmunity, HumoralImmunity, InnateVirus Diseases

Identifiers

PMID23397531
PMCPMC3827890
OpenAlexW1991305909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.